Ghrp-6 — reference
Earlier-generation ghrelin-receptor agonist, notable for pronounced appetite stimulation.
Regulatory status
Not FDA-Approved. Not approved for human use. Research chemical. Banned by WADA.
Reported cautions
Pharmacokinetics
Published figures give an elimination half-life of ~10–60 minutes (commonly cited ~15–26 min). Figures vary more here than for GHRP-2; treat as an estimate.
This figure is tagged Limited data in our evidence system. The available data does not support a confident single figure, so this entry is flagged accordingly. Read any curve built from it as illustrative only. You can see the shape this implies between doses in the Half-Life Visualizer, and compare it against every other compound in the Half-Life Data Table. Our sourcing page explains what each tier means.
Remember that an estimated curve is a model built from a population figure, not a measurement of your blood. Individual clearance varies, and for depot injections the figure describes release from the injection site rather than the compound clearing. Half-life explained →
What Peptide Plug does and does not publish
This page carries regulatory status, general context and published pharmacokinetics. It carries no dose, frequency or cycle information — that is a deliberate editorial line, because dosing is a clinical decision rather than reference data. We also do not sell, supply, source or link to vendors for any compound.
Frequently asked
Is Ghrp-6 FDA-approved?
What is the half-life of Ghrp-6?
How reliable is that half-life figure?
What cautions are associated with Ghrp-6?
Does Peptide Plug publish dosing for Ghrp-6?
Does Peptide Plug sell Ghrp-6?
Related tools
Free, no account required.